Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin vs Dalteparin for Perioperative Thromboembolic Prophylaxis in Dialysis Patients
NCT00260988Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Oct 2003
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tinzaparin in thromboembolism (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Pharmacokinetic profiles (pre-dialysis anti-Xa levels). Started Oct 2003; status: completed.
02
Drugs
tinzaparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT00260988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260988.